 Immunoglobulin E
"Immunoglobulin E" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
| Descriptor ID |
D007073
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.312 D12.776.124.790.651.114.619.312 D12.776.377.715.548.114.619.312
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin E".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin E".
This graph shows the total number of publications written about "Immunoglobulin E" by people in this website by year, and whether "Immunoglobulin E" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 3 | 3 | | 1996 | 4 | 2 | 6 | | 1997 | 1 | 2 | 3 | | 1998 | 0 | 1 | 1 | | 1999 | 1 | 4 | 5 | | 2001 | 2 | 3 | 5 | | 2002 | 2 | 2 | 4 | | 2003 | 4 | 6 | 10 | | 2004 | 2 | 4 | 6 | | 2005 | 4 | 3 | 7 | | 2006 | 2 | 7 | 9 | | 2007 | 2 | 3 | 5 | | 2008 | 0 | 6 | 6 | | 2009 | 4 | 6 | 10 | | 2010 | 4 | 8 | 12 | | 2011 | 1 | 5 | 6 | | 2012 | 2 | 10 | 12 | | 2013 | 2 | 8 | 10 | | 2014 | 3 | 8 | 11 | | 2015 | 5 | 7 | 12 | | 2016 | 4 | 3 | 7 | | 2017 | 0 | 18 | 18 | | 2018 | 1 | 6 | 7 | | 2019 | 4 | 5 | 9 | | 2020 | 1 | 10 | 11 | | 2021 | 2 | 2 | 4 | | 2022 | 0 | 4 | 4 | | 2023 | 2 | 7 | 9 | | 2024 | 4 | 8 | 12 | | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulin E" by people in Profiles.
-
Szefler S, Corren J, Silverberg JI, Okragly A, Sun Z, Natalie CR, Zitnik R, Siu K, Blauvelt A. Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II). Immunotherapy. 2024; 16(20-22):1211-1216.
-
Brough HA, Kim EH, Anagnostou A, Lanser BJ, Chinthrajah RS, Sindher SB. Treatment of Food Allergy: Immunotherapy, Omalizumab, or Both. J Allergy Clin Immunol Pract. 2025 Apr; 13(4):731-739.
-
Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, Alvaro-Lozano M, Ballmer-Weber B, Barni S, Beyer K, Bindslev-Jensen C, Brough HA, Buyuktiryaki B, Chu D, Del Giacco S, Dunn-Galvin A, Eberlein B, Ebisawa M, Eigenmann P, Eiwegger T, Feeney M, Fernandez-Rivas M, Fiocchi A, Fisher HR, Fleischer DM, Giovannini M, Gray C, Hoffmann-Sommergruber K, Halken S, O'B Hourihane J, Jones CJ, Jutel M, Knol EF, Konstantinou GN, Lack G, Lau S, Mejias AM, Marchisotto MJ, Meyer R, Mortz CG, Moya B, Muraro A, Nilsson C, de Oliveira LCL, O'Mahony L, Papadopoulos NG, Perrett KP, Peters R, Podesta M, Poulsen LK, Roberts G, Sampson H, Schwarze J, Smith P, Tham E, Untersmayr E, Van Ree R, Venter C, Vickery B, Vlieg-Boerstra B, Werfel T, Worm M, Du Toit G, Skypala I. EAACI guidelines on the management of IgE-mediated food allergy. Allergy. 2025 Jan; 80(1):14-36.
-
Anagnostou A, Greenhawt M, Shaker M, Vickery BP, Wang J. Food allergy yardstick: Where does omalizumab fit? Ann Allergy Asthma Immunol. 2025 Jan; 134(1):110-121.
-
Venter C, Pickett-Nairne K, Glueck DH, Nevalainen J, Greenhawt M, Metsala J, Sauder KA, Perng W, Fleischer DM, Leung D, Dabelea D. Bidirectional associations between IgE-mediated food allergy and atopic dermatitis. Pediatr Allergy Immunol. 2024 Aug; 35(8):e14223.
-
Meyer R, Vandenplas Y, Lozinsky AC, Vieira MC, Berni Canani R, du Toit G, Dupont C, Giovannini M, Uysal P, Cavkaytar O, Knibb R, Fleischer DM, Nowak-Wegrzyn A, Venter C. Diagnosis and management of food allergy-induced constipation in young children-An EAACI position paper. Pediatr Allergy Immunol. 2024 Jun; 35(6):e14163.
-
Murphy KR, Beuther DA, Chipps BE, Wise RA, McCann WA, Reibman J, George M, Gilbert I, Eudicone JM, Gandhi HN, Ross M, Coyne KS, Zeiger RS. Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction Ability. J Allergy Clin Immunol Pract. 2024 Aug; 12(8):2092-2101.e4.
-
Katial JM, Hoyte FCL, Khatiwada A, Katial RK. Allergen skin test responses in broad U.S. asthma population in those with and without rhinitis. Allergy Asthma Proc. 2024 May 01; 45(3):158-165.
-
Porsbjerg CM, Townend J, Bergeron C, Christoff GC, Katsoulotos GP, Larenas-Linnemann D, Tran TN, Al-Lehebi R, Bosnic-Anticevich SZ, Busby J, Hew M, Kostikas K, Papadopoulos NG, Pfeffer PE, Popov TA, Rhee CK, Sadatsafavi M, Tsai MJ, Ulrik CS, Al-Ahmad M, Altraja A, Beastall A, Bulathsinhala L, Carter V, Cosio BG, Fletton K, Hansen S, Heaney LG, Hubbard RB, Kuna P, Murray RB, Nagano T, Pini L, Cano Rosales DJ, Schleich F, Wechsler ME, Amaral R, Bourdin A, Brusselle GG, Chen W, Chung LP, Denton E, Fonseca JA, Hoyte F, Jackson DJ, Katial R, Kirenga BJ, Koh MS, Lawkiedraj A, Lehtim?ki L, Liew MF, Mahboub B, Martin N, Menzies-Gow AN, Pang PH, Papaioannou AI, Patel PH, Perez-De-Llano L, Peters MJ, Ricciardi L, Rodr?guez-C?ceres B, Solarte I, Tay TR, Torres-Duque CA, Wang E, Zappa M, Abisheganaden J, Assing KD, Costello RW, Gibson PG, Heffler E, M?spero J, Nicola S, Perng Steve DW, Puggioni F, Salvi S, Sheu CC, Sirena C, Taill? C, Tan TL, Bjermer L, Canonica GW, Iwanaga T, Jim?nez-Maldonado L, Taube C, Brussino L, Price DB. Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma. Front Immunol. 2024; 15:1361891.
-
Casale TB, Fiocchi A, Greenhawt M. A practical guide for implementing omalizumab therapy for food allergy. J Allergy Clin Immunol. 2024 Jun; 153(6):1510-1517.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|